Document Type : Review Article
Authors
Department of Nanotechnology, Jabir Ibn Hayyan Institute, Technical and Vocational Training Organization, Isfahan, Iran
Abstract
Personalized medicine as a revolutionary in medicine provides medical services tailored to a person's molecular characteristics. In personalized medicine, the physician with the knowledge of information in the person’s molecular profile (omics) can prescribe an effective drug with minimal side effects and appropriate dose for changing lifestyle and diet to prevent and treat diseases.
Theoretically, the molecular profile of each individual could give some information about risk of diseases, the person responses to medications and the relationship between person molecular profile and certain traits, such as lactose intolerance and diet-specific adaptation.
In the past, it was impossible to confirm the presence or absence of mutations in an individual's genome, as the use of molecular techniques such as PCR was very time consuming and was associated with many limitations. On the other hand, many traits and diseases are multigenic and the consequence of interaction with environment. Furthermore mathematical models for measuring genetic risk were not developed.
In recent years, creation of individual genetic profile with determination of a person's genotype and all known mutations in a short time and at low cost became possible, due to advances in microarray technology, computer science and statistics.
In parallel with genomics, advances in other multidisciplinary sciences such as nanotechnology and systematic biology have facilitated the disease interactions at the cellular and molecular scale. Nanomedicine has provided the control of drug release profiles using design and fabrication of nanostructured devices, so it is hoped that by combining these information and examining their interactions, better contribution to human health will be achieved. In this review, we focused on nanotechnology applications and solutions that impact on personalized medicine and accelerate its progress and development.
Keywords
in silicones for topical and transdermal drug delivery.
Therapeutic Delivery 6:827-839.
2- Armstrong J. P. and Stevens M. M. (2019) Emerging
technologies for tissue engineering: from gene
editing to personalized medicine. Tissue Engineering
Part A 25:688-692.
3- Baumann B., Wittig R. and Lindén M. (2017)
Mesoporous silica nanoparticles in injectable
hydrogels: factors influencing cellular uptake and
viability. Nanoscale 9:12379-12390.
4-Choi W. I., Lee J. H., Kim J.-Y., Heo S. U., Jeong Y.
Y., Kim Y. H. and Tae G. (2015) Targeted antitumor
efficacy and imaging via multifunctional nano-
carrier conjugated with anti-HER2 trastuzumab.
Nanomedicine: Nanotechnology, Biology and
Medicine 11:359-368.
5-Cui H., Yu Y., Li X., Sun Z., Ruan J., Wu Z., Qian
J. and Yin J. (2019) Direct 3D printing of a tough
hydrogel incorporated with carbon nanotubes for
bone regeneration. Journal of Materials Chemistry B
7:7207-7217.
6-Dittler M. L., Unalan I., Grünewald A., Beltrán A.
M., Grillo C. A., Destch R., Gonzalez M. C. and
Boccaccini A. R. (2019) Bioactive glass (45S5)-
based 3D scaffolds coated with magnesium and
zinc-loaded hydroxyapatite nanoparticles for tissue
engineering applications. Colloids and Surfaces B:
Biointerfaces 182:110346.
7- Elingarami S., Li X. and He N. (2013) Applications
of nanotechnology, next generation sequencing
and microarrays in biomedical research. Journal of
Nanoscience and Nanotechnology 13:4539-4551.
8-Emerich D. F. and Thanos C. G. (2007) Targeted
nanoparticle-based drug delivery and diagnosis.
Journal of drug targeting 15:163-183.
9-Gabizon A. A. (2001) Pegylated liposomal
doxorubicin: metamorphosis of an old drug into a
new form of chemotherapy. Cancer investigation
19:424-436.
10- Gallo M., Favila A. and Glossman-Mitnik D. (2007)
DFT studies of functionalized carbon nanotubes
and fullerenes as nanovectors for drug delivery of
antitubercular compounds. Chemical Physics Letters
447:105-109.
11- Gautier J., Allard-Vannier E., Munnier E., Soucé
M. and Chourpa I. (2013) Recent advances in
theranostic nanocarriers of doxorubicin based on iron
oxide and gold nanoparticles. Journal of Controlled
Release 169:48-61.
12-Hosseini V., Mirrahimi M., Shakeri-Zadeh A.,
Koosha F., Ghalandari B., Maleki S., Komeili A.
and Kamrava S. K. (2018) Multimodal cancer cell
therapy using Au@ Fe2O3 core–shell nanoparticles
in combination with photo-thermo-radiotherapy.
Photodiagnosis and photodynamic therapy 24:129-
135.
13-Huang Y., He S., Cao W., Cai K. and Liang X.-J.
(2012) Biomedical nanomaterials for imaging-
guided cancer therapy. Nanoscale 4:6135-6149.
14-Initiative N. N. 2011. What is nanotechnology?
National Nanotechnology Initiative website.
15-Karagkiozaki V., Logothetidis S. and Pappa A.-M.
(2015) Nanomedicine for atherosclerosis: molecular
imaging and treatment. Journal of biomedical
nanotechnology 11:191-210.
16-Kumar R., Shin W. S., Sunwoo K., Kim W. Y., Koo
S., Bhuniya S. and Kim J. S. (2015) Small conjugate-
based theranostic agents: an encouraging approach
for cancer therapy. Chemical Society Reviews
44:6670-6683.
17- Lee J. E., Lee N., Kim T., Kim J. and Hyeon T. (2011)
Multifunctional mesoporous silica nanocomposite
nanoparticles for theranostic applications. Accounts
of chemical research 44:893-902.
18-Lee J. M., Moon J. Y., Kim T. H., Lee S. W., Ahrberg
C. D. and Chung B. G. (2018) Conductive hydrogel/
nanowire micropattern-based sensor for neural
stem cell differentiation. Sensors and Actuators B:
Chemical 258:1042-1050.
19-Lin P., Moore D. and Allhoff F. 2009. What is
nanotechnology and why does it matter?: from
science to ethics. John Wiley & Sons.
20- Manzano M. and Vallet Regí M. (2020) Mesoporous
silica nanoparticles for drug delivery. Advanced
functional materials 30:1902634.
21-Matsumura Y. (2008) Polymeric micellar delivery
systems in oncology. Japanese journal of clinical
oncology 38:793-802.
22-Mokhtarzadeh A., Tabarzad M., Ranjbari J., de la
Guardia M., Hejazi M. and Ramezani M. (2016)
Aptamers as smart ligands for nano-carriers targeting.
TrAC Trends in Analytical Chemistry 82:316-327.
23-Nikoleli G.-P., Siontorou C. G., Nikolelis D. P.,
Bratakou S., Karapetis S. and Tzamtzis N. (2018)
Biosensors based on microfluidic devices lab-on-a-
chip and microfluidic technology. Nanotechnology
and biosensors:375-394.
24-Noah N. M. and Ndangili P. M. (2019) Current trends
of nanobiosensors for point-of-care diagnostics.
Journal of Analytical Methods in Chemistry 2019.
P. A., Russell J., Newman M., Amantea M. A. and
Kaplan L. D. (1996) Doxorubicin encapsulated in
liposomes containing surface bound polyethylene
glycol: pharmacokinetics, tumor localization,
and safety in patients with AIDS related Kaposi’s
sarcoma. The Journal of Clinical Pharmacology
36:55-63.
26-Rangasamy M. (2011) Nano technology: a review.
Journal of applied pharmaceutical science 1:8-16.
27-Sakamoto J., Godin B., Hu Y., Blanco E., van
de Ven A. L., Vellaichamy A., Murphy M. B., La
Francesca S., Schuenemeyer T. and Given B. (2013)
Nanotechnology toward advancing personalized
medicine. 2013) Handbook of Personalized
Medicine. CRC Press, Boca Raton:1-714.
28-Schiffman J. D., Fisher P. G. and Gibbs P. (2015)
Early detection of cancer: past, present, and future.
American Society of Clinical Oncology Educational
Book 35:57-65.
29-Torchilin V. P. (2007) Targeted pharmaceutical
nanocarriers for cancer therapy and imaging. The
AAPS journal 9:E128-E147.
30-Veiseh O., Tang B. C., Whitehead K. A., Anderson
D. G. and Langer R. (2015) Managing diabetes with
nanomedicine: challenges and opportunities. Nature
Reviews Drug Discovery 14:45-57.
31- Wu X., Yang H., Yang W., Chen X., Gao J., Gong
X., Wang H., Duan Y., Wei D. and Chang J. (2019)
Nanoparticle-based diagnostic and therapeutic
systems for brain tumors. Journal of Materials
Chemistry B 7:4734-4750.
32-Yadid M., Feiner R. and Dvir T. (2019) Gold
nanoparticle-integrated scaffolds for tissue
engineering and regenerative medicine. Nano letters
19:2198-2206.
33-Yang D. (2021) Application of nanotechnology in
the COVID-19 pandemic. International journal of
nanomedicine 16:623.
34-Zhang H., Xia J., Pang X., Zhao M., Wang B.,
Yang L., Wan H., Wu J. and Fu S. (2017) Magnetic
nanoparticle-loaded electrospun polymeric
nanofibers for tissue engineering. Materials Science
and Engineering: C 73:537-543.
)